VitalConnect has launched its latest cardiac monitoring patch, the VitalPatch RTM, for patients who require extended Holter monitoring. The wearable biosensor looks for 21 different cardiac ...

The FDA has granted an Emergency Use Authorization (EUA) to VitalConnect that allows its VitalPatch wearable sensor to further monitor patients undergoing COVID-19 treatment. As per the agency's ...

VitalConnect raised $100 million to accelerate commercialization of its ambulatory cardiac monitoring device, the company said Wednesday. The company sells a disposable patch that records a patient’s ...

SAN JOSE, Calif.--(BUSINESS WIRE)--VitalConnect ®, Inc., a leader in remote and in-hospital monitoring biosensor technology, announced today it has launched its VitalPatch RTM mobile cardiac telemetry ...

HOUSTON — As the fight against the novel coronavirus continues, doctors at Houston Methodist Hospital are turning to a Band-Aid-sized tool to monitor the virus. Known as VitalPatch, doctors place the ...

Please provide your email address to receive an email when new articles are posted on . VitalConnect announced the launch of its AI-based continuous remote cardiac monitoring solution for patients who ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

A stick-on medical-grade biosensor will soon allow hospitals to monitor patients' health via a cloud-based system. If a problem is detected, the biosensor uses Bluetooth to connect to a mobile phone ...

Patient monitoring company VitalConnect has raised $100m through a combination of equity and debt capital. The US company stated that it would use the funds to expand the commercial presence of its ...

Brian Cooley is CNET's Editor at large and has been with the brand since 1995. He currently focuses on electrification of vehicles but also follows the big trends in smart home, digital healthcare, 5G ...

SAN JOSE, Calif.--(BUSINESS WIRE)--VitalConnect ®, Inc., a leader in remote and in-hospital wearable biosensor technology, announced today that it has begun the TELESTAR-TAVR clinical study ...